StreetInsider.com News Articles

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

Tue, 02 Jun 2026 08:01:00 -0400

SAN DIEGO, June 2, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal year end March 31, 2026, at 4:15 p.m. ET on Wednesday, June 10, 2026.

Management will host a conference call on Wednesday, June 10, 2026, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session.

Interested parties

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

Tue, 02 Jun 2026 08:01:00 -0400

Interested parties

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

Tue, 02 Jun 2026 08:01:00 -0400

Interested parties

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

Tue, 02 Jun 2026 08:01:00 -0400

Interested parties

Aethlon Medical monitors Ebola outbreak, cites device preparedness

Thu, 21 May 2026 08:02:01 -0400

Aethlon Medical Inc. (NASDAQ: AEMD) announced it is monitoring the current Bundibugyo Ebola virus outbreak in Democratic Republic of the Congo and Uganda and remains prepared to engage with healthcare authorities regarding potential use of its Hemopurifier technology.

The World Health Organization and public health agencies have identified the outbreak as involving the Bundibugyo strain of Ebola virus. Health authorities have expressed concern about cross-border transmission and potential regional spread, according to the company's statement based on public health reports.

The Hemopurifier is an investigational medical device designed to remove enveloped viruses and tumor-derived extracellular vesicles from blood circulation. During the 2014

Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness

Thu, 21 May 2026 08:01:00 -0400

SAN DIEGO, May 21, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it is actively monitoring developments related to the current Bundibugyo Ebola virus outbreak in Democratic Republic of the Congo and Uganda and remains prepared to engage with global healthcare and regulatory authorities regarding the potential investigational use of its Hemopurifier® technology.